These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 1716263)

  • 1. Intravenous gamma-globulin in myasthenia gravis: interaction with anti-acetylcholine receptor autoantibodies.
    Liblau R; Gajdos P; Bustarret FA; el Habib R; Bach JF; Morel E
    J Clin Immunol; 1991 May; 11(3):128-31. PubMed ID: 1716263
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intravenous immune globulin in myasthenia gravis.
    Gajdos P
    Clin Exp Immunol; 1994 Jul; 97 Suppl 1(Suppl 1):49-51. PubMed ID: 8033435
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunoadsorption apheresis versus intravenous immunoglobulin therapy for exacerbation of myasthenia gravis.
    Yasuda M; Uzawa A; Ozawa Y; Kojima Y; Onishi Y; Akamine H; Kuwabara S
    Scand J Immunol; 2022 Feb; 95(2):e13122. PubMed ID: 34796975
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Muscle-specific kinase myasthenia gravis IgG4 autoantibodies cause severe neuromuscular junction dysfunction in mice.
    Klooster R; Plomp JJ; Huijbers MG; Niks EH; Straasheijm KR; Detmers FJ; Hermans PW; Sleijpen K; Verrips A; Losen M; Martinez-Martinez P; De Baets MH; van der Maarel SM; Verschuuren JJ
    Brain; 2012 Apr; 135(Pt 4):1081-101. PubMed ID: 22396395
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Subunit specificity of the acetylcholine receptor antibodies in double seropositive myasthenia gravis.
    Zouvelou V; Michail M; Belimezi M; Zisimopoulou P
    Muscle Nerve; 2021 Apr; 63(4):E36-E37. PubMed ID: 33471417
    [No Abstract]   [Full Text] [Related]  

  • 6. A solid-phase enzyme immunoassay for anti-acetylcholine receptor antibody in myasthenia gravis patients.
    Kobayashi N; Sugita H; Terada E; Ghoda A; Okudaira H; Ogita T; Miyamoto T
    J Immunol Methods; 1984 Oct; 73(2):267-72. PubMed ID: 6386990
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acetylcholine receptor antibody as a diagnostic test for myasthenia gravis: results in 153 validated cases and 2967 diagnostic assays.
    Vincent A; Newsom-Davis J
    J Neurol Neurosurg Psychiatry; 1985 Dec; 48(12):1246-52. PubMed ID: 4087000
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Myasthenia gravis. Anti-acetylcholine receptor antibodies.
    Cerrato D; Ariano C; La Mantia L; Fiacchino F; Sghirlanzoni A; Nespolo A; Corridori F; Cornelio F
    Ital J Neurol Sci; 1981 May; 2(2):165-71. PubMed ID: 7333817
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Maintenance IVIg therapy in myasthenia gravis does not affect disease activity.
    Hellmann MA; Mosberg-Galili R; Lotan I; Steiner I
    J Neurol Sci; 2014 Mar; 338(1-2):39-42. PubMed ID: 24267740
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-MuSK positivity on plasmapheresis liquid in a double seronegative myasthenia gravis patient.
    Renard D; Candon S; Jacob M; Trusson R; Reboul P
    Acta Neurol Belg; 2018 Mar; 118(1):119-120. PubMed ID: 28608313
    [No Abstract]   [Full Text] [Related]  

  • 11. Serum Acetylcholine Receptor Antibodies Before the Clinical Onset of Myasthenia Gravis.
    Strijbos E; Verschuuren JJGM; Kuks JBM
    J Neuromuscul Dis; 2018; 5(2):261-264. PubMed ID: 29865092
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transient neonatal myasthenia gravis in a baby born to a mother with new-onset anti-MuSK-mediated myasthenia gravis.
    O'carroll P; Bertorini TE; Jacob G; Mitchell CW; Graff J
    J Clin Neuromuscul Dis; 2009 Dec; 11(2):69-71. PubMed ID: 19955986
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adsorption column for myasthenia gravis treatment: Medisorba MG-50.
    Nakaji S; Hayashi N
    Ther Apher Dial; 2003 Feb; 7(1):78-84. PubMed ID: 12921120
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Antibodies to acetylcholine receptor. Diagnosis and therapeutic interest in myasthenia gravis (author's transl)].
    de Crousaz G
    Ann Chir; 1980 Mar; 34(3):188-92. PubMed ID: 7369693
    [No Abstract]   [Full Text] [Related]  

  • 15. Plasma exchange in myasthenia gravis: effect on anti-AChR antibodies and other autoantibodies.
    Thorlacius S; Lefvert AK; Aarli JA; Gilhus NE; Halvorsen K; Hofstad H; Matre R; Tönder O
    Acta Neurol Scand; 1986 Dec; 74(6):486-90. PubMed ID: 3825504
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-dose intravenous immunoglobulin in transient neonatal myasthenia gravis.
    Bassan H; Muhlbaur B; Tomer A; Spirer Z
    Pediatr Neurol; 1998 Feb; 18(2):181-3. PubMed ID: 9535308
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-MuSK antibody myasthenia gravis: clinical findings and response to treatment in two large cohorts.
    Guptill JT; Sanders DB; Evoli A
    Muscle Nerve; 2011 Jul; 44(1):36-40. PubMed ID: 21674519
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-acetylcholine receptor antibodies in myasthenia gravis. Part 3. The effect of thymectomy.
    Oosterhuis HJ; Limburg PC; Hummel-Tappel E; Van den Burg W; The TH
    J Neurol Sci; 1985 Jul; 69(3):335-43. PubMed ID: 4031948
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Leukoplasmapheresis for myasthenia gravis. Acetylcholine receptor antibody production.
    Seybold ME; Tsoukas C; Lindstrom J; Fong S; Vaughan J
    Arch Neurol; 1982 Jul; 39(7):433-5. PubMed ID: 6980639
    [No Abstract]   [Full Text] [Related]  

  • 20. [Heterogeneity of acetylcholine receptor antibodies in patients with myasthenia gravis].
    Kalies I; Heinz F; Kaschka WP; Druschky KF; Kalden JR
    Klin Wochenschr; 1984 Apr; 62(8):377-85. PubMed ID: 6727277
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.